This may be because most infants undergoing scleral buckling or vitrectomy in our study are stage 4A ROP cases, and 7/9 (77.78%) of them were first treated with intravitreal injection of anti-VEGF agents. Here, VEGFA is linked to retinopathy of prematurity.